YESCARTA

gilead sciences canada inc🇨🇦 Health Canada

Approval Id: ad4c5b1a2c3e9494
Drug Approval Canada Name: YESCARTA
Product Name: YESCARTA
Status: Marketed
Status Date: 2019-11-27
Original Market Date: 2019-11-27
Din: 02485648
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 26:12.00
Atc Original: L01XL03 AXICABTAGENE CILOLEUCEL
Atc Name: l 01 xl 03
Aig Number: 0161211001
Company Name: gilead sciences canada inc
Company Address: 400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2

AXICABTAGENE CILOLEUCEL

200000000 CELLS / BAG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ad4c5b1a2c3e9494

Type

Standard